Fri, January 15, 2021

Mayank Mamtani Downgraded (ARCT) to Hold and Decreased Target to $77 on, Jan 15th, 2021

Mayank Mamtani of B. Riley Securities, Downgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Hold and Decreased Target from $138 to $77 on, Jan 15th, 2021.

Mayank has made no other calls on ARCT in the last 4 months.



There are 6 other peers that have a rating on ARCT. Out of the 6 peers that are also analyzing ARCT, 3 agree with Mayank's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Madhu Kumar of "Baird" Downgraded from Buy to Hold and Decreased Target to $69 on, Tuesday, December 29th, 2020
  • Steven Seedhouse of "Raymond James" Downgraded from Buy to Hold on, Tuesday, December 29th, 2020
  • Ed Arce of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $50 on, Tuesday, December 29th, 2020


These are the ratings of the 3 analyists that currently disagree with Mayank


  • John Abbott of "Wells Fargo" Initiated at Buy on, Thursday, January 7th, 2021
  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Strong Sell and Held Target at $77 on, Wednesday, December 23rd, 2020
  • Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $65 on, Tuesday, October 6th, 2020